DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Injectable products, like Mylan’s EpiPen (epinephrine injection), are currently the go-to treatment for patients undergoing ...

It’s beginning to look a lot like Christmas, at least at the Fairmont Armory it Is. Vincent’s Promotions LLC is hosting their ...

A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

The 13th Annual Bob Huggins Fish Fry is set for Saturday, Feb. 1, 2025. Proceeds from the fry, presented by Little General ...

Pharmaceutical company Viatris (VTRS 13.52%) reported third-quarter 2024 financial results on Thursday, Nov. 7, that topped ...

A suit against Novartis and Vitaris by Henrietta Lacks’ estate hinges on questions about the morality and legality of using ...

Heritage is ponying up $10 million while Apotex is set to pay $39.1 million over the companies’ alleged roles in a sweeping ...

At the time, Synthon said its development partner Mylan had “once again overcome Teva’s attempts to restrict MS [multiple ...

The global glucosamine supplement market is projected to grow from USD 583.6 million in 2023 to USD 932.7 million by 2033, expanding at a CAGR of 4.8%, according to Future Market Insights. The rising ...